Viele K - Search Results

1

Use of historical control data for assessing treatment effects in clinical trials.

Viele K, Berry S, Neuenschwander B, Amzal B, Chen F, Enas N, Hobbs B, Ibrahim JG, Kinnersley N, Lindborg S, Micallef S, Roychoudhury S, Thompson L. Viele K, et al. Pharm Stat. 2014 Jan-Feb;13(1):41-54. doi: 10.1002/pst.1589. Epub 2013 Aug 5. Pharm Stat. 2014. PMID: 23913901 Free PMC article. Review.

2

An adaptive, phase II, dose-finding clinical trial design to evaluate L-carnitine in the treatment of septic shock based on efficacy and predictive probability of subsequent phase III success.

Lewis RJ, Viele K, Broglio K, Berry SM, Jones AE. Lewis RJ, et al. Among authors: viele k. Crit Care Med. 2013 Jul;41(7):1674-8. doi: 10.1097/CCM.0b013e318287f850. Crit Care Med. 2013. PMID: 23514753 Free PMC article.

3

Interpretation of Clinical Trials That Stopped Early.

Viele K, McGlothlin A, Broglio K. Viele K, et al. JAMA. 2016 Apr 19;315(15):1646-7. doi: 10.1001/jama.2016.2628. JAMA. 2016. PMID: 27092832 No abstract available.

4

Bayesian Analysis: Using Prior Information to Interpret the Results of Clinical Trials.

Quintana M, Viele K, Lewis RJ. Quintana M, et al. Among authors: viele k. JAMA. 2017 Oct 24;318(16):1605-1606. doi: 10.1001/jama.2017.15574. JAMA. 2017. PMID: 29067406 No abstract available.

5

Phase 3 adaptive trial design options in treatment of complicated urinary tract infection.

Viele K, Mundy LM, Noble RB, Li G, Broglio K, Wetherington JD. Viele K, et al. Pharm Stat. 2018 Nov;17(6):811-822. doi: 10.1002/pst.1892. Epub 2018 Aug 27. Pharm Stat. 2018. PMID: 30152129

6

Using Bayesian adaptive designs to improve phase III trials: a respiratory care example.

Ryan EG, Bruce J, Metcalfe AJ, Stallard N, Lamb SE, Viele K, Young D, Gates S. Ryan EG, et al. Among authors: viele k. BMC Med Res Methodol. 2019 May 14;19(1):99. doi: 10.1186/s12874-019-0739-3. BMC Med Res Methodol. 2019. PMID: 31088354 Free PMC article.

7

Comparison of methods for control allocation in multiple arm studies using response adaptive randomization.

Viele K, Broglio K, McGlothlin A, Saville BR. Viele K, et al. Clin Trials. 2020 Feb;17(1):52-60. doi: 10.1177/1740774519877836. Epub 2019 Oct 19. Clin Trials. 2020. PMID: 31630567

8

Comparison of response adaptive randomization features in multiarm clinical trials with control.

Viele K, Saville BR, McGlothlin A, Broglio K. Viele K, et al. Pharm Stat. 2020 Sep;19(5):602-612. doi: 10.1002/pst.2015. Epub 2020 Mar 21. Pharm Stat. 2020. PMID: 32198968

9

Reducing Patient Burden in Clinical Trials Through the Use of Historical Controls: Appropriate Selection of Historical Data to Minimize Risk of Bias.

Lim J, Wang L, Best N, Liu J, Yuan J, Yong F, Zhang L, Walley R, Gosselin A, Roebling R, Viele K. Lim J, et al. Among authors: viele k. Ther Innov Regul Sci. 2020 Jul;54(4):850-860. doi: 10.1007/s43441-019-00014-4. Epub 2019 Dec 10. Ther Innov Regul Sci. 2020. PMID: 32557308

10

Strategies to Promote ResiliencY (SPRY): a randomised embedded multifactorial adaptative platform (REMAP) clinical trial protocol to study interventions to improve recovery after surgery in high-risk patients.

Reitz KM, Seymour CW, Vates J, Quintana M, Viele K, Detry M, Morowitz M, Morris A, Methe B, Kennedy J, Zuckerbraun B, Girard TD, Marroquin OC, Esper S, Holder-Murray J, Newman AB, Berry S, Angus DC, Neal M. Reitz KM, et al. Among authors: viele k. BMJ Open. 2020 Sep 29;10(9):e037690. doi: 10.1136/bmjopen-2020-037690. BMJ Open. 2020. PMID: 32994242 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page